These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35098540)

  • 61. Neutralisation of circulating SARS-CoV-2 delta and omicron variants by convalescent plasma and SARS-CoV-2 hyperimmune intravenous human immunoglobulins for treatment of COVID-19.
    Zahra FT; Bellusci L; Grubbs G; Golding H; Khurana S
    Ann Rheum Dis; 2022 Jul; 81(7):1044-1045. PubMed ID: 35144925
    [No Abstract]   [Full Text] [Related]  

  • 62. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults.
    Self WH; Stewart TG; Wheeler AP; El Atrouni W; Bistran-Hall AJ; Casey JD; Cataldo VD; Chappell JD; Cohn CS; Collins JB; Denison MR; de Wit M; Dixon SL; Duggal A; Edwards TL; Fontaine MJ; Ginde AA; Harkins MS; Harrington T; Harris ES; Hoda D; Ipe TS; Jaiswal SJ; Johnson NJ; Jones AE; Laguio-Vila M; Lindsell CJ; Mallada J; Mammen MJ; Metcalf RA; Middleton EA; Mucha S; O'Neal HR; Pannu SR; Pulley JM; Qiao X; Raval JS; Rhoads JP; Schrager H; Shanholtz C; Shapiro NI; Schrantz SJ; Thomsen I; Vermillion KK; Bernard GR; Rice TW;
    Trials; 2021 Mar; 22(1):221. PubMed ID: 33743799
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19.
    Kesici S; Yavuz S; Bayrakci B
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12526-12527. PubMed ID: 32398378
    [No Abstract]   [Full Text] [Related]  

  • 65. Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
    Zimmerli A; Monti M; Fenwick C; Eckerle I; Beigelman-Aubry C; Pellaton C; Jaton K; Dumas D; Stamm GM; Infanti L; Andreu-Ullrich H; Germann D; Mean M; Vollenweider P; Stadelmann R; Prella M; Comte D; Guery B; Gachoud D; Rufer N
    Front Immunol; 2021; 12():613502. PubMed ID: 33968017
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Convalescent plasma, political narrative, and public health ethics in the Covid-19 pandemic.
    Agrawal S; Agarwal A; Jain Y
    Indian J Med Ethics; 2021; VI(3):1-7. PubMed ID: 34287194
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of Convalescent Plasma in the Management of COVID-19.
    Dandachi D; Khalaf SA
    Mo Med; 2021; 118(2):118. PubMed ID: 33840851
    [No Abstract]   [Full Text] [Related]  

  • 68. Transfusion-related acute lung injury in a COVID-19-positive convalescent plasma recipient: a case report.
    Amrutiya V; Patel R; Baghal M; Patel B; Waykole T; Patel H; Govil S; Lo A
    J Int Med Res; 2021 Aug; 49(8):3000605211032814. PubMed ID: 34412545
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Convalescent plasma for COVID-19 complicated by ARDS due to TRALI.
    Wang KY; Shah P; Pierce M
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33509890
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Manufacturing of convalescent plasma of COVID-19 patients: Aspects of quality.
    Hähnel V; Peterhoff D; Bäuerlein V; Brosig AM; Pamler I; Johnson C; Bica A; Totir M; Ossner T; Stemmer B; Toelge M; Schütz A; Niller HH; Schmidt B; Wagner R; Gessner A; Burkhard R; Offner R
    PLoS One; 2020; 15(12):e0243967. PubMed ID: 33351831
    [TBL] [Abstract][Full Text] [Related]  

  • 71. COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma.
    Sanfilippo F; La Rosa V; Oliveri F; Astuto M
    Am J Respir Crit Care Med; 2021 Jan; 203(2):257-258. PubMed ID: 33085908
    [No Abstract]   [Full Text] [Related]  

  • 72. Convalescent plasma for covid-19.
    Estcourt LJ; Roberts DJ
    BMJ; 2020 Sep; 370():m3516. PubMed ID: 32933945
    [No Abstract]   [Full Text] [Related]  

  • 73. Convalescent Plasma and COVID-19.
    Malani AN; Sherbeck JP; Malani PN
    JAMA; 2020 Aug; 324(5):524. PubMed ID: 32530454
    [No Abstract]   [Full Text] [Related]  

  • 74. Convalescent plasma from people vaccinated after COVID-19 infection.
    Jabal KA; Wiegler KB; Edelstein M
    Lancet Microbe; 2021 May; 2(5):e171-e172. PubMed ID: 33778791
    [No Abstract]   [Full Text] [Related]  

  • 75. Early safety indicators of COVID-19 convalescent plasma in 5000 patients.
    Joyner MJ; Wright RS; Fairweather D; Senefeld JW; Bruno KA; Klassen SA; Carter RE; Klompas AM; Wiggins CC; Shepherd JR; Rea RF; Whelan ER; Clayburn AJ; Spiegel MR; Johnson PW; Lesser ER; Baker SE; Larson KF; Ripoll JG; Andersen KJ; Hodge DO; Kunze KL; Buras MR; Vogt MN; Herasevich V; Dennis JJ; Regimbal RJ; Bauer PR; Blair JE; Van Buskirk CM; Winters JL; Stubbs JR; Paneth NS; Verdun NC; Marks P; Casadevall A
    J Clin Invest; 2020 Sep; 130(9):4791-4797. PubMed ID: 32525844
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion.
    Xia X; Li K; Wu L; Wang Z; Zhu M; Huang B; Li J; Wang Z; Wu W; Wu M; Li W; Li L; Cai Y; Bosco B; Zhong A; Liu X; Lv T; Gan Z; Chen G; Pan Y; Liu C; Zhang K; Xu X; Wang C; Wang Q
    Blood; 2020 Aug; 136(6):755-759. PubMed ID: 32573724
    [No Abstract]   [Full Text] [Related]  

  • 77. Isopathic Remedy Prepared from Convalescent Plasma as a Therapeutic Option for COVID-19?
    Prajapati S
    Homeopathy; 2020 Aug; 109(3):184-185. PubMed ID: 32645727
    [No Abstract]   [Full Text] [Related]  

  • 78. COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience.
    Fabricius MM; Dandachi D
    Mo Med; 2021; 118(1):74-80. PubMed ID: 33551490
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Challenges of Convalescent Plasma Therapy on COVID-19.
    Zhao Q; He Y
    J Clin Virol; 2020 Jun; 127():104358. PubMed ID: 32305026
    [No Abstract]   [Full Text] [Related]  

  • 80. [COVID-19: blood sufficiency versus convalescent plasma?].
    Contreras M
    Rev Med Chil; 2020 Jun; 148(6):721-723. PubMed ID: 33480368
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.